← Back to Search

Mobile Application

Learn to Quit-HIV for Tobacco Use Disorder

N/A
Waitlist Available
Led By Lauren Pacek, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 years or older
Current interest in quitting smoking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This study is evaluating whether an app can help individuals with HIV quit smoking.

Eligible Conditions
  • Tobacco Use Disorder
  • HIV/AIDS
  • Smoking Cessation

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
App Usability as Measured by the Systems Usability Scale
Duration of Daily App Use
Frequency of App Use as Measured by Interactions Per Day
+4 more
Secondary outcome measures
7-day Point Prevalence Abstinence
Number of Participants With at Least One Adverse Event Determined to be Related to the Study Interventions
Number of Quit Attempts
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Learn to Quit-HIVExperimental Treatment3 Interventions
A smartphone app developed by the research team designed for people with HIV that provides Acceptance and Commitment Therapy skills to address smoking cessation. This app intervention is combined with an 8-week course of nicotine replacement therapy (NRT) patches, along with technical smartphone coaching for the first 4 weeks of the study.
Group II: QuitGuideActive Control3 Interventions
A smartphone app developed by the National Cancer Institute which uses smoking cessation recommendations contained in the US DHHS (United States Department of Health and Human Services) Clinical Practice Guidelines. This app intervention is combined with an 8-week course of nicotine replacement therapy (NRT) patches, along with technical smartphone coaching for the first 4 weeks of the study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Learn to Quit-HIV
2021
N/A
~60
Smartphone coaching
2021
N/A
~60
Nicotine patch
2015
Completed Phase 4
~7450

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,351 Previous Clinical Trials
3,407,783 Total Patients Enrolled
28 Trials studying Tobacco Use Disorder
5,157 Patients Enrolled for Tobacco Use Disorder
National Institutes of Health (NIH)NIH
2,682 Previous Clinical Trials
6,930,747 Total Patients Enrolled
45 Trials studying Tobacco Use Disorder
26,169 Patients Enrolled for Tobacco Use Disorder
Lauren Pacek, PhDPrincipal InvestigatorDuke University
1 Previous Clinical Trials

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~12 spots leftby Mar 2025